Nuclear Myocardial Perfusion Imaging Use Decreasing
Use of nuclear myocardial perfusion imaging exams dropped sharply between 2006 and 2011, but substitute imaging studies haven’t increased.
Use of nuclear myocardial perfusion imaging (MPI) has decreased significantly, according to a recent study in JAMA.
Researchers from Kaiser Permanente Medical Center in San Francisco, Calif., examined trends of MPI use from 2000 to 2011. The researchers obtained data regarding patients, aged 30 years or older, who underwent MPI within the healthcare delivery system.
The findings showed that MPI was used for 302,506 patients at 19 facilities. The imaging use increased by a relative 41 percent from 2000 to 2006. However, from 2006 to 2011, MPI use dropped by a relative 51 percent. Use dropped by 58 percent among outpatients and 31 percent among inpatients and for patients under age 65.
When looking to see if other imaging tests increased as a result of the MPI decrease, the researchers found that use of cardiac CT did increase and could have accounted for 5 percent of the observed decline in overall MPI use if performed as a substitute.
“The substantial reduction in MPI use demonstrates the ability to reduce testing on a large scale with anticipated reductions in health care costs,” wrote authors Edward J. McNulty, MD, and colleagues.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
